Breaking News
0

Samuel Rae

Joined: Jul 21, 2013
  • Analysis & Opinion

Samuel Rae's Opinion & Analysis
A complete archive of Samuel Rae's articles, including current analysis & opinion.

News just hit the press in the biotechnology space that Shire plc. (NASDAQ:SHPG) has picked up the rights to a new drug from development stage biotechnology company AB Biosciences. Here's a look at...
U.S. Gold Corp. (NASDAQ:USAU) is picking up attention at the start of this week on news that the company has just announced (and released) the results from an end of 2017 drilling effort at one of its...
Early investors have made a fortune in Bitcoin (BTC), the first and best-known cryptocurrency. In 2017, Bitcoin appreciated 1,500%. That’s nothing to sneeze at. There is a number of other...
2017 was the year of the initial coin offering (ICO). In August 2017 alone, more than 400 companies sought to raise development and operational capital through issuing company specific tokens in...
What if we can grow fully functional skin, hair follicles and all, with just a biopsy? It’s been done successfully in large animal studies already, and one biotech firm called PolarityTE Inc....
2018 could be an incredible year for patients in the diabetes space. A number of fresh treatments have either picked up approval at the end of this year (and, in turn, are due to launch early next...
Of the huge number of cryptocurrencies that have hit the markets over the last one or two years, a few have stood out as potentially game-changing and, in turn, have attracted a large amount of...
Back at the start of November, NEM (XEM) tokens went for around $0.18 a piece. Fast-forward a few weeks and the coin now looks set to hit a dollar a piece very near term. Market capitalization is...
Picking up a position in a healthcare stock ahead of a major catalyst can be a risky strategy but is also one that serves up the potential for a high degree of reward on the position in question. In...
Ardelyx Inc. (NASDAQ:ARDX) just announced that it has scrapped one of its lead development assets. On the back of the news, the company is trading relatively flat, suggesting that the markets...